Nurix Therapeutics (NRIX) Times Interest Earned (2019 - 2026)
Nurix Therapeutics' (NRIX) quarterly Times Interest Earned came in at -$235.51 in Q2 2026, down 143.69% year-on-year from $539.07 in Q2 2025, and down 97.33% on a QoQ basis from -$119.35 in Q1 2026.
Nurix Therapeutics (NRIX) Times Interest Earned (2019 - 2026) Analysis & Trends
Nurix Therapeutics (NRIX) has 8 years of Times Interest Earned data on file, last reported at -$235.51 in Q2 2026.
- On a quarterly basis, Times Interest Earned fell 143.69% year-over-year to -$235.51 in Q2 2026; TTM through May 2026 was -$121.16, a 157.3% decrease from a year earlier, with the FY2025 full-year figure at -$0.86, up 8.06% from the prior year.
- Times Interest Earned for Q2 2026 stood at -$235.51, down from -$119.35 in the prior quarter.
- Over the last five years, Times Interest Earned for NRIX reached as high as -$0.92 in Q2 2022 and fell as low as -$913.85 in Q3 2025.
- Historically, Times Interest Earned has averaged -$134.5 across 5 years, with a median of -$35.28 in 2022.
- On a YoY basis, Times Interest Earned climbed as much as 53.96% in 2023 and fell as far as 3586.53% in 2023.
- Year by year, Times Interest Earned stood at -$35.28 in 2022, then soared by 53.96% to -$16.24 in 2023, then sank by 85.75% to -$30.17 in 2024, then slumped by 61.44% to -$48.71 in 2025, then slumped by 383.52% to -$235.51 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were -$235.51 in Q2 2026, -$119.35 in Q1 2026, and -$48.71 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Nurix Therapeutics | 2.64 Bn | 2.19 Bn | - | -235.51 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -235.51 |
| Feb 28, 2026 | -119.35 |
| Nov 30, 2025 | -48.71 |
| Aug 31, 2025 | -913.85 |
| May 31, 2025 | -96.64 |
| Feb 28, 2025 | -29.23 |
| Nov 30, 2024 | -30.17 |
| Aug 31, 2024 | -546.11 |
| May 31, 2024 | -121.35 |
| Feb 29, 2024 | -23.58 |
| Nov 30, 2023 | -16.24 |
| Aug 31, 2023 | -35.82 |
| Feb 28, 2023 | -30.95 |
| Nov 30, 2022 | -35.28 |
| Aug 31, 2022 | -0.97 |
| May 31, 2022 | -0.92 |
| Feb 28, 2022 | -1.76 |
| Nov 30, 2021 | -30.56 |
| Aug 31, 2021 | -0.34 |
| May 31, 2021 | -0.40 |